Home

Indoco Remedies Ltd Quarterly Result

Image

Indoco Remedies Ltd

NSE: INDOCO

Net Profit - Last Quarter

₹ -10.01 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Indoco Remedies Ltd for the Sep '24 is ₹ 434.22 crore as compare to the Jun '24 revenue of ₹ 432.52 crore. This represent the growth of 0.39304823%.
  • The ebitda of Indoco Remedies Ltd for the Sep '24 is ₹ 41.81 crore as compare to the Jun '24 ebitda of ₹ 48.8 crore. This represent the decline of -14.323766%.
  • The net profit of Indoco Remedies Ltd for the Sep '24 is ₹ -10.01 crore as compare to the Jun '24 net profit of ₹ 1.82 crore. This represent the decline of -650%.

Results Analysis

Market Price of Indoco Remedies Ltd

1M

1Y

3Y

5Y

Monitoring Indoco Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 2025323.9
14 Jan 2025325.35
13 Jan 2025323.65
10 Jan 2025326.65
09 Jan 2025335
08 Jan 2025336.25
07 Jan 2025336.4
06 Jan 2025333.9
03 Jan 2025336.25
02 Jan 2025337.9

Historical Revenue of Indoco Remedies Ltd

No data available

* All values are in crore

Historical EBITDA of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Net Profit of Indoco Remedies Ltd

No data available

* All values are in crore

Indoco Remedies Ltd News Hub

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg

Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New Drug Appl

Read more

21 Aug 2024

Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets

The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been granted a Comp

Read more

21 Aug 2024

Indoco Remedies fixes record date for final dividend

Indoco Remedies has fixed 19 September 2024 as record date for determining entitlement of members to

Read more

30 Aug 2024

Indoco Remedies AGM scheduled

Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be held on 26 Se

Read more

31 Aug 2024

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Indoco Remedies Ltd

What key financial metrics are included in Indoco Remedies Ltd's quarterly results?

Key financial metrics in Indoco Remedies Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Indoco Remedies Ltd announce its quarterly results?

Indoco Remedies Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Indoco Remedies Ltd's quarterly performance impact its stock price?

Indoco Remedies Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Indoco Remedies Ltd's quarterly results on dividends?

The impact of Indoco Remedies Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Indoco Remedies Ltd's quarterly results?

Yes, Indoco Remedies Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions